Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|August 16, 2022
Differential molecular mechanistic behavior of HDACs in cancer progressionTashvinder Singh, Prabhsimran Kaur, Paramdeep Singh, et al.Mitochondrion|September 1, 2024
Mitochondrial bioenergetics of breast cancerTashvinder Singh, Kangan Sharma, Laxmipriya Jena, et al.Molecular Neurobiology|March 27, 2024
Gene Expression Analysis in T2DM and Its Associated Microvascular Diabetic Complications: Focus on Risk Factor and RAAS PathwayLaxmipriya Jena, Prabhsimran Kaur, Tashvinder Singh, et al.Regenerative Medicine|May 18, 2023
Comprehensive analysis of culture conditions governing differentiation of MSCs into articular chondrocytesHarsh Vikram Singh, Lakshmana Das, Rhuthuparna Malayil, et al.Medical Oncology (Northwood, London, England)|May 11, 2023
Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genesRhuthuparna Malayil, Yogita Chhichholiya, Kanika Vasudeva, et al.RSC Medicinal Chemistry|July 19, 2024
Design, synthesis, and anticancer assessment of structural analogues of (<i>E</i>)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-<i>a</i>]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-<i>a</i>]quinoxaline-based non-covalent EGFR inhibitorManvendra Kumar, Kiran T Patil, Pritam Maity, et al.Current Protein & Peptide Science|June 7, 2023
Trehalose and its Diverse Biological PotentialEva Sharma, P S Shruti, Shagun Singh, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 3, 2025
Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R SignalingPrabhsimran Kaur, Tashvinder Singh, Laxmipriya Jena, et al.Frontiers in Oncology|July 17, 2020
Metabolic Adaptations in Cancer Stem CellsUmesh Prasad Yadav, Tashvinder Singh, Pramit Kumar, et al.Molecules (Basel, Switzerland)|April 3, 2021
Design and Synthesis of Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer AssessmentManvendra Kumar, Gaurav Joshi, Sahil Arora, et al.Pageof 2